University research records
University of Osijek
5 imported, source-linked research records. Published in the last two years.
Published in the last two years
Back to university profile →5 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to University of Osijek are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–5 of 5 matching records. Counts update as records arrive.
γδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes
September 11, 2026 · 0 citations · Open access
Open original record →Hemoglobin Trajectories on SGLT2 Inhibitor Therapy in Heart Failure: Anemia Marks Adverse Prognosis While Erythrocytosis Is Transient and Not Associated with Adverse Outcomes
July 13, 2026 · 0 citations · Open access
Open original record →Impact of Antidiabetic Medications on IgG and Plasma Protein N-Glycosylation in Type 2 Diabetes Patients
June 22, 2026 · 0 citations · Open access
Open original record →Heart Failure Etiology and 6-Month Cardiorenal Recovery Patterns After Early In-Hospital SGLT2 Inhibitor Initiation in HFrEF: A Prospective Real-World Cohort
May 24, 2026 · 1 citations · Open access
Open original record →GLP-1 Receptor Agonist Semaglutide and SGLT2 Inhibitors after Acute Coronary Syndrome in Patients with Diabetes: Real-World Comparative Outcomes from an Observational Registry
April 14, 2026 · 0 citations
Open original record →